• <samp id="egceo"></samp>
  • <strike id="egceo"></strike>
    • 18717796589
    18717796589

    證據文獻

    NO 論文 登載期刊 PM ID 全文鏈接 中文鏈接
    1 輔助免疫細胞療法與全身系統性療法結合治療實體瘤的療效 Anticancer Research 42: 4179-4187 / 2022 35896218 https://ar.iiarjournals.org/content/42/8/4179 http://www.vpaidu.com/laitian/results/22.html
    2 食管癌對免疫細胞療法和低劑量納武單抗聯合治療有反應 Journal of Medical Case Reports 15, Article number: 191 / 2021 33827668 https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-020-02634-z http://www.vpaidu.com/laitian/results/23.html
    3 免疫細胞療法治療晚期/復發性乳腺癌的預后因素 Anticancer Research 41:4133-4141 / 2021 34281884 https://ar.iiarjournals.org/content/41/8/4133.long http://www.vpaidu.com/laitian/results/1.html
    4 過繼性T細胞免疫治療對晚期胰腺癌患者免疫學指標及預后的影響 CYTOTHERAPYFeb;23(2):137-145/2020 32907781 https://linkinghub.elsevier.com/retrieve/pii/S1465-3249(20)30813-6 http://www.vpaidu.com/laitian/results/2.html
    5 接受一線化療免疫治療的轉移性結直腸癌患者的免疫狀態變化 Anticancer Research 40:4763-4771 / 2020 32727803 https://ar.iiarjournals.org/content/40/8/4763.long http://www.vpaidu.com/laitian/results/3.html
    6 過繼免疫細胞治療子宮頸神經內分泌癌 Anticancer Research 40:4741-4748 / 2020 32727800 https://ar.iiarjournals.org/content/40/8/4763 http://www.vpaidu.com/laitian/results/4.html
    7 免疫細胞治療子宮內膜癌和宮頸癌預后因素的回顧性研究 Anticancer Research 40:4729-4740 / 2020 32727799 https://ar.iiarjournals.org/content/40/8/4729.long http://www.vpaidu.com/laitian/results/5.html
    8 適應性免疫細胞治療對晚期胃癌患者免疫細胞譜的影響 Cancer Med 9(14):4907-4917 / 2020 32529780 https://ar.iiarjournals.org/content/40/8/4729.long http://www.vpaidu.com/laitian/results/6.html
    9 γδT細胞免疫治療實體瘤預后因素的研究 CYTOTHERAPY Jun;22(6):329-336 / 2020 32303429 https://pubmed.ncbi.nlm.nih.gov/32303429/ http://www.vpaidu.com/laitian/results/7.html
    10 免疫細胞聯合一線化療治療結直腸癌的預后因素:一項回顧性研究 Anticancer Research 39: 4525-4532 / 2019 31366555 https://pubmed.ncbi.nlm.nih.gov/31366555/ http://www.vpaidu.com/laitian/results/8.html
    11 免疫細胞治療胰腺癌患者的預后因素 Anticancer Research 38 (7) 4353-4360 / 2018 29970573 https://pubmed.ncbi.nlm.nih.gov/29970573/ http://www.vpaidu.com/laitian/results/9.html
    12 腫瘤內注射唑來膦酸鹽沖擊樹突狀細胞、靜脈過繼活化T淋巴細胞和吉西他濱聯合綜合免疫治療不可切除的局部晚期胰腺癌的I/II期臨床研究 Oncotarget Dec5;9(2):2838-2847./2017 29416816 https://pubmed.ncbi.nlm.nih.gov/29416816/ http://www.vpaidu.com/laitian/results/10.html
    13 全身靜脈過繼轉移自體淋巴因子激活的αβT細胞改善替莫唑胺誘導的膠質瘤患者淋巴細胞減少 Anticancer Research Jul;37(7):3921-3932./2017 28668896 https://pubmed.ncbi.nlm.nih.gov/28668896/ http://www.vpaidu.com/laitian/results/11.html
    14 過繼免疫聯合化療治療IV期結直腸癌的臨床研究(COMVI研究) Anticancer Research Jul;37(7):3941-3946. / 2017 28668898 https://pubmed.ncbi.nlm.nih.gov/28668898/ http://www.vpaidu.com/laitian/results/12.html
    15 過繼免疫細胞療法治療晚期胃癌的回顧性研究 Anticancer Research Jul;37(7):3947-3954. / 2017 28668899 https://pubmed.ncbi.nlm.nih.gov/28668899/ http://www.vpaidu.com/laitian/results/13.html
    16 mRNA-EP制備的腫瘤血管靶向CAR-T細胞用于臨床研究的免疫學質量和性能 Mol Ther Oncolytics.Nov 16;3:16024. / 2016 27909701 https://pubmed.ncbi.nlm.nih.gov/27909701/ http://www.vpaidu.com/laitian/results/14.html
    17 活化αβT細胞過繼免疫化療治療IV期結直腸癌 Anticancer Research Jul;36(7):3741-6. / 2016 27354648 https://pubmed.ncbi.nlm.nih.gov/27354648/ http://www.vpaidu.com/laitian/results/15.html
    18 WT1抗原在多種實體癌細胞中表達的免疫組織化學分析 Anticancer Research 36(7):3715-3724 / 2016 27354645 https://pubmed.ncbi.nlm.nih.gov/27354645/ http://www.vpaidu.com/laitian/results/16.html
    19 自體免疫細胞治療改善不同類型晚期癌癥患者的免疫功能受損 Anticancer Research 36(7):3715-3724 / 2016 26168498 https://pubmed.ncbi.nlm.nih.gov/26168498/ http://www.vpaidu.com/laitian/results/17.html
    20 免疫細胞治療在不同類型晚期癌癥患者中的前瞻性安全性評價 Anticancer Research 35(8):4535-4543 / 2015 25075106 https://pubmed.ncbi.nlm.nih.gov/25075106/ http://www.vpaidu.com/laitian/results/18.html
    21 在晚期癌癥患者中評估細胞免疫狀態受損和失衡,并通過過繼性T細胞免疫治療恢復T細胞免疫狀態 International Immunopharmacology18(1):90-97. / 2014 24269583 https://pubmed.ncbi.nlm.nih.gov/24269583/ http://www.vpaidu.com/laitian/results/19.html
    22 封閉流式電穿孔系統治療實體瘤的自體腫瘤溶解物樹突狀細胞疫苗免疫治療 Anticancer Research 33(7):2971-6. / 2013 23780988 https://pubmed.ncbi.nlm.nih.gov/23780988/ http://www.vpaidu.com/laitian/results/20.html
    23 晚期肺癌過繼性活化T淋巴細胞免疫治療中觀察到的生存期延長:一項多中心歷史性隊列研究的結果 Cancer Immunology, Immunotherapy 61:1781-1790. / 2012 22422103 https://pubmed.ncbi.nlm.nih.gov/22422103/ http://www.vpaidu.com/laitian/results/21.html